Status:

COMPLETED

Non-pharmacological Mitigation of Psoriasis

Lead Sponsor:

Medical University of Lodz

Conditions:

Psoriasis

Stress

Eligibility:

All Genders

18-45 years

Phase:

NA

Brief Summary

In the past few years, research has provided evidence for a possibility of dampening immune system by one's will after undergoing a specific training program. Aim of this study was to verity the effic...

Detailed Description

Psoriasis is a skin disease of an unknown origin. Current understanding of its pathophysiology focuses on an undefined imbalance between the immune system and the nervous system. In this study the res...

Eligibility Criteria

Inclusion

  • Aforementioned Age
  • Confirmed diagnosis of plaque psoriasis

Exclusion

  • ultraviolet therapy 2 months prior or introduced later during intervention period
  • lifestyle changes defined as changing jobs, introducing a new diet, or sport, or changing their place of residence
  • kidney disease
  • heart disease
  • active infection
  • pregnancy
  • breastfeeding

Key Trial Info

Start Date :

February 19 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 6 2020

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT04745429

Start Date

February 19 2020

End Date

October 6 2020

Last Update

September 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical Univeristy of Lodz, Chair of Clinical Immunology and Rheumatology

Lodz, Łódź Voivodeship, Poland, 92-213